Fulcrum Therapeutics Inc (NASDAQ: FULC) on Tuesday, soared 6.26% from the previous trading day, before settling in for the closing price of $7.67. Within the past 52 weeks, FULC’s price has moved between $2.32 and $10.11.
A company in the Healthcare sector has jumped its sales by 54.59% annually for the last half of the decade. The company achieved an average annual earnings per share of -637.50%. With a float of $47.97 million, this company’s outstanding shares have now reached $54.11 million.
Fulcrum Therapeutics Inc (FULC) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Fulcrum Therapeutics Inc is 11.36%, while institutional ownership is 91.15%. The most recent insider transaction that took place on May 08 ’25, was worth 2,520. In this transaction Principal Accounting Officer of this company sold 498 shares at a rate of $5.06, taking the stock ownership to the 14,062 shares.
Fulcrum Therapeutics Inc (FULC) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.31 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.29) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -637.50% per share during the next fiscal year.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators
Fulcrum Therapeutics Inc (FULC) is currently performing well based on its current performance indicators. A quick ratio of 17.70 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Fulcrum Therapeutics Inc (FULC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.62 million. That was better than the volume of 0.57 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.94%.
During the past 100 days, Fulcrum Therapeutics Inc’s (FULC) raw stochastic average was set at 50.44%, which indicates a significant increase from 30.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.78 in the past 14 days, which was higher than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.41, while its 200-day Moving Average is $6.07. However, in the short run, Fulcrum Therapeutics Inc’s stock first resistance to watch stands at $8.43. Second resistance stands at $8.71. The third major resistance level sits at $9.17. If the price goes on to break the first support level at $7.69, it is likely to go to the next support level at $7.23. Assuming the price breaks the second support level, the third support level stands at $6.95.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Key Stats
Market capitalization of the company is 441.07 million based on 54,118K outstanding shares. Right now, sales total 80,000 K and income totals -9,730 K. The company made 0 K in profit during its latest quarter, and -19,600 K in sales during its previous quarter.
